Drug Research

Karolinska Institute researchers have come up with a promising antibody medication candidate for the medication of non-alcoholic fatty liver disease. There is presently no treatment for non-alcoholic fatty liver disease, which affects individuals with type 2 diabetes and can develop...

NUS Academic Medical Centre and SingHealth in Singapore have announced a gift of $50 million, which will be transformational, from the Lee Foundation that will aid in providing support for the advancement of research and innovation via programmes as...

The University of Freiburg researchers have found out that the release of prometastatic factors is influenced by the skeleton of the cell, known as actin. As per a research team that was led by Dr. Robert Grosse and Dr. Carsten...

A new partnership with Thailand to share the expertise of genome sequencing, research collaboration, education and training opportunities, as well as genomics data handling will help UK patients. A MoU has been inked between deputy Prime Minister of Thailand, Anutin...

According to a survey from Fitch Solutions, South Korea's pharmaceutical market attractiveness is expected to stay strong despite ongoing concerns about the country's slow pace of drug authorizations. According to the analysis, the pharmaceutical business will remain competitive due to...

A novel strategy for 2023–25 adopted by the Medicines Patent Pool looks to lessen the inequalities in access by way of enhancing the affordability as well as availability of health products across low- and-middle-income countries (LMIC). The MPP which is...

The European Commission (EC) has granted marketing authorisation for Regeneron Pharmaceuticals and Sanofi’s Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE). Dupixent’s expanded authorisation in the European Union (EU) is intended to treat 12 years and older patients with EoE, who...